Literature DB >> 832614

Breakthrough in treatment of patent ductus arteriosus.

D R Lines.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 832614     DOI： 10.2165/00003495-197713010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management.

Authors:  J A Kitterman; L H Edmunds; G A Gregory; M A Heymann; W H Tooley; A M Rudolph
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

2.  Hemodynamic and renal effects of a prostaglandin, PGA 1, in subjects with essential hypertension.

Authors:  A A Carr
Journal:  Am J Med Sci       Date:  1970-01       Impact factor: 2.378

3.  Chloroquine as prostaglandin antagonist in treatment of patent ductus arteriosus.

Authors:  G Collins; E Outerbridge; M S Manku; D F Horrobin
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

4.  Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.

Authors:  M A Heymann; A M Rudolph; N H Silverman
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

5.  Pharmacologic closure of patent ductus arteriosus in the premature infant.

Authors:  W F Friedman; M J Hirschklau; M P Printz; P T Pitlick; S E Kirkpatrick
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

6.  Medical manipulation of the ductus arteriosus.

Authors:  R B Elliott; M B Starling; J M Neutze
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

7.  The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro.

Authors:  M B Starling; R B Elliott
Journal:  Prostaglandins       Date:  1974-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.